Accropeutics has developed a robust pipeline focusing on inflammation, fibrosis, autoimmune diseases and cancer
| asset | rights | indication | Discovery | Pre-Clinical | IND | Phase I | Phase II |
|---|---|---|---|---|---|---|---|
|
AC-003 Learn more |
 |
IPF |
|
||||
 |
GVHD |
|
|||||
 |
Rheumatoid Arthritis |
|
|||||
 |
Ulcerative Colitis |
|
|||||
|
AC-101 Learn more |
 |
IBD |
|
||||
 |
Anti-inflammation |
|
|||||
|
AC-201 Learn more |
 |
Psoriasis |
|
||||
 |
SLE |
|
|||||
|
AC-203 |
 |
Rheumatoid Arthritis |
|
||||
 |
AS, HS, AD, AA, SLE |
|
|||||
|
AC-301 |
 |
DLBCL |
|
||||
 |
Leukemia |
|
|||||
 |
Anti-inflammation |
|
